These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18639460)

  • 21. PAK signaling in oncogenesis.
    Molli PR; Li DQ; Murray BW; Rayala SK; Kumar R
    Oncogene; 2009 Jul; 28(28):2545-55. PubMed ID: 19465939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of p21-activated kinases in pancreatic cancer.
    Yeo D; He H; Baldwin GS; Nikfarjam M
    Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation-dependent activity-based conformational changes in P21-activated kinase family members and screening of novel ATP competitive inhibitors.
    Gul M; Fakhar M; Najumuddin ; Rashid S
    PLoS One; 2019; 14(11):e0225132. PubMed ID: 31738805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scaffolding function of PAK in the PDK1-Akt pathway.
    Higuchi M; Onishi K; Kikuchi C; Gotoh Y
    Nat Cell Biol; 2008 Nov; 10(11):1356-64. PubMed ID: 18931661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p21-activated kinases and gastrointestinal cancer.
    He H; Baldwin GS
    Biochim Biophys Acta; 2013 Jan; 1833(1):33-9. PubMed ID: 23092728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how.
    Wang Y; Guo F
    Biol Rev Camb Philos Soc; 2022 Apr; 97(2):615-639. PubMed ID: 34811887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAK as a therapeutic target in gastric cancer.
    Li X; Liu F; Li F
    Expert Opin Ther Targets; 2010 Apr; 14(4):419-33. PubMed ID: 20146633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
    Menges CW; Sementino E; Talarchek J; Xu J; Chernoff J; Peterson JR; Testa JR
    Mol Cancer Res; 2012 Sep; 10(9):1178-88. PubMed ID: 22798428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAK thread from amoeba to mammals.
    Kumar A; Molli PR; Pakala SB; Bui Nguyen TM; Rayala SK; Kumar R
    J Cell Biochem; 2009 Jul; 107(4):579-85. PubMed ID: 19350548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CK2beta interacts with and regulates p21-activated kinases in Drosophila.
    Mentzel B; Jauch E; Raabe T
    Biochem Biophys Res Commun; 2009 Feb; 379(2):637-42. PubMed ID: 19121626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Participation of group I p21-activated kinases in neuroplasticity.
    Koth AP; Oliveira BR; Parfitt GM; Buonocore Jde Q; Barros DM
    J Physiol Paris; 2014; 108(4-6):270-7. PubMed ID: 25174326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p21-activated kinase inhibitors.
    Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
    Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging importance of group II PAKs.
    Wells CM; Jones GE
    Biochem J; 2010 Jan; 425(3):465-73. PubMed ID: 20070256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of Nanomedicine to Target Signaling by the PAK Kinases for Disease Treatment.
    Wang Y; Minden A
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders.
    Zhang K; Wang Y; Fan T; Zeng C; Sun ZS
    Protein Cell; 2022 Jan; 13(1):6-25. PubMed ID: 33306168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p21-Activated kinases as promising therapeutic targets in hematological malignancies.
    Wu A; Jiang X
    Leukemia; 2022 Feb; 36(2):315-326. PubMed ID: 34697424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of p-21-activated kinases in cancer progression.
    King H; Nicholas NS; Wells CM
    Int Rev Cell Mol Biol; 2014; 309():347-87. PubMed ID: 24529727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate.
    Ha BH; Davis MJ; Chen C; Lou HJ; Gao J; Zhang R; Krauthammer M; Halaban R; Schlessinger J; Turk BE; Boggon TJ
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16107-12. PubMed ID: 22988085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signalling to cancer cell invasion through PAK family kinases.
    Whale A; Hashim FN; Fram S; Jones GE; Wells CM
    Front Biosci (Landmark Ed); 2011 Jan; 16(3):849-64. PubMed ID: 21196207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P-21-activated protein kinase-1 functions as a linker between insulin and Wnt signaling pathways in the intestine.
    Sun J; Khalid S; Rozakis-Adcock M; Fantus IG; Jin T
    Oncogene; 2009 Sep; 28(35):3132-44. PubMed ID: 19581924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.